Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 7, 2000 - Issue 3
95
Views
60
CrossRef citations to date
0
Altmetric
Original Article

Amyloid peptide channels: Blockade by zinc and inhibition by Congo red (amyloid channel block)

, , &
Pages 194-199 | Received 28 Apr 1999, Accepted 26 Oct 1999, Published online: 06 Jul 2009
 

Abstract

Amyloid peptides are the major constituents of amyloid deposits in various amyloid diseases including Alzheimer's disease, type II diabetes mellitus, prion diseases and others. The hallmark of amyloid is the binding of the dye, Congo red, which creates characteristic staining due to the dye's ability to bind the beta sheet aggregates referred to as amyloid. Previous reports have demonstrated that several cytotoxic, amyloidogenic peptides can form ion channels in planar phospholipid bilayer membranes and have suggested that these channels may represent the pathogenic mechanism of cell and tissue destruction in amyloid disease. Furthermore, zinc and Congo red can ameliorate or prevent the pathogenic effect of certain amyloid peptides. We report here that zinc at micromolar concentrations caused a reversible blockade of islet amyloid polypeptide (IAPP, amylin) and PrP 106–126 channels whereas calcium and magnesium did not. Congo red completely inhibited channel formation if preincubated with amyloid peptides, but had no effect on IAPP or PrP 106–126 channels once formed. These results suggest a requirement for aggregation for the formation of amyloid peptide channels and are consistent with the “channel hypothesis” of amyloid disease. They also suggest potential avenues for ameliorative therapy of these illnesses.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.